Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Decade in review—arrhythmias

Cardiac fibrillation—challenges and evolving solutions

Nature Reviews Cardiology volume 11, pages 626–627 (2014)Cite this article

Subjects

Cardiac rhythm disorders, or 'arrhythmias', are major sources of morbidity and mortality, and have been challenging to treat because classic pharmacological therapies are often ineffective and sometimes dangerous. In the past decade, groundbreaking developments have revolutionized the management of arrhythmias and prepared the groundwork for new advances in the future.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Major advances in arrhythmia research during the past decade.

References

  1. Bardy, G. H. et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352, 225–237 (2005).

    Article  CAS  Google Scholar 

  2. Haïssaguerre, M. et al. Sudden cardiac arrest associated with early repolarization. N. Engl. J. Med. 358, 2016–2023 (2008).

    Article  Google Scholar 

  3. Itzhaki, I. et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225–229 (2011).

    Article  CAS  Google Scholar 

  4. Roy, D. et al. Rhythm control versus rate control for atrial fibrillation and heart failure N. Engl. J. Med. 358, 2667–2677 (2008).

    Article  CAS  Google Scholar 

  5. Van Gelder, I. C. et al. Lenient versus strict rate control in patients with atrial fibrillation. N. Engl. J. Med. 362, 1363–1373 (2010).

    Article  CAS  Google Scholar 

  6. Connolly, S. J. et al. Dronedarone in high-risk permanent atrial fibrillation. N. Engl. J. Med. 365, 2268–2276 (2011).

    Article  CAS  Google Scholar 

  7. Cosedis Nielsen, J. et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N. Engl. J. Med. 367, 1587–1595 (2012).

    Article  Google Scholar 

  8. Narayan, S. M. et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J. Am. Coll. Cardiol. 60, 628–636 (2012).

    Article  Google Scholar 

  9. Connolly, S. J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139–1151 (2009).

    Article  CAS  Google Scholar 

  10. Abed, H. S. et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 310, 2050–2060 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

S.N. is funded by the Canadian Institutes of Health Research (6957 and 44365) and the Heart and Stroke Foundation of Canada.

Author information

Authors and Affiliations

  1. Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, 5000 Belanger Street East, Montreal, H1T 1C8, QC, Canada

    Stanley Nattel

Authors
  1. Stanley Nattel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stanley Nattel.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nattel, S. Cardiac fibrillation—challenges and evolving solutions. Nat Rev Cardiol 11, 626–627 (2014). https://doi.org/10.1038/nrcardio.2014.133

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2014.133

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing